company

Stanley Medical Research Institute

as of 2026-07-01
Monitor thisAsk about this
at a glance
92 trials sponsored · 60 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

60 assets
CannabidiolMinocyclineOlanzapineRisperidoneACP-104AcetazolamideArtemisininAspirinAtomoxetine (Strattera)BF2.649Bacopa monnieriBetahistineCapsule with folate, Vitamin B12 & pyridoxineCholecalciferolCognitive retrainingCognitive trainingCromoglycateCurcuminD-serineEstradiolEstradiol/dyhydroprogestroneEthyl-eicosapentaenoic acid (EPA)ExenatideExperimental: Valacyclovir treatmentFlunarizineGalantamineInert CompoundIntravenous immunoglobulinKuvanL-CarnosineL-TheanineL-carnosine (dietary supplement)L-lysineL-tetrahydropalmatine (30mg)Lactose CapsulesLorazepamLuteolinMelatoninMemantineMultivitaminN-Acetyl CysteineNardostachys jatamansiNeuroadaptive cognitive trainingOdansetron plus simvastatinOmega 3 fatty acidsOxytocinPantoprazolePentazocinePergolidePimozidePlasma ExchangePravastatinPregnenoloneProbiotic SupplementProgesteroneRaloxifeneRaloxifene HydrochlorideRiluzoleSiltuximabSimvastatin

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Cannabidiol
small molecule
drug
Minocycline
small molecule
drug
Olanzapine
small molecule
drug
Risperidone
small molecule
drug
ACP-104
small molecule
drug
Acetazolamide
small molecule
drug
Artemisinin
DIETARY_SUPPLEMENT
drug
Aspirin
small molecule
drug